Business Description
Clene Inc
NAICS : 311999
SIC : 2834
ISIN : US1856341029
Share Class Description:
FRA:84C0: Ordinary SharesDescription
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.64 | |||||
| Equity-to-Asset | -0.13 | |||||
| Debt-to-Equity | -5.55 | |||||
| Debt-to-EBITDA | -0.77 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -14.77 | |||||
| Beneish M-Score | -5.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -19 | |||||
| 3-Year EBITDA Growth Rate | 24.8 | |||||
| 3-Year EPS without NRI Growth Rate | 19.1 | |||||
| 3-Year FCF Growth Rate | 35.9 | |||||
| 3-Year Book Growth Rate | 162.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 42.71 | |||||
| Future 3-5Y Total Revenue Growth Rate | 250.93 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.05 | |||||
| 9-Day RSI | 27.12 | |||||
| 14-Day RSI | 32.83 | |||||
| 6-1 Month Momentum % | -21.05 | |||||
| 12-1 Month Momentum % | -42.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.83 | |||||
| Quick Ratio | 0.82 | |||||
| Cash Ratio | 0.61 | |||||
| Days Inventory | 278.21 | |||||
| Days Sales Outstanding | 93.63 | |||||
| Days Payable | 6312.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -29.2 | |||||
| Shareholder Yield % | 5.78 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 78.62 | |||||
| Operating Margin % | -7908.08 | |||||
| Net Margin % | -8556.77 | |||||
| FCF Margin % | -5640.67 | |||||
| ROE % | -523.13 | |||||
| ROA % | -78.4 | |||||
| ROIC % | -100.63 | |||||
| ROC (Joel Greenblatt) % | -242.69 | |||||
| ROCE % | -140.8 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 64.84 | |||||
| EV-to-EBIT | -1.32 | |||||
| EV-to-Forward-EBIT | -1.04 | |||||
| EV-to-EBITDA | -1.4 | |||||
| EV-to-Forward-EBITDA | -1.07 | |||||
| EV-to-Revenue | 98.22 | |||||
| EV-to-Forward-Revenue | 91.89 | |||||
| EV-to-FCF | -1.75 | |||||
| Earnings Yield (Greenblatt) % | -75.76 | |||||
| FCF Yield % | -71.54 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Clene Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.386 | ||
| EPS (TTM) (€) | -4.923 | ||
| Beta | -0.6 | ||
| Volatility % | 122.5 | ||
| 14-Day RSI | 32.83 | ||
| 14-Day ATR (€) | 0.269585 | ||
| 20-Day SMA (€) | 4.6805 | ||
| 12-1 Month Momentum % | -42.03 | ||
| 52-Week Range (€) | 3.555 - 9.72 | ||
| Shares Outstanding (Mil) | 7.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Clene Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Clene Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Clene Inc Frequently Asked Questions
What is Clene Inc(FRA:84C0)'s stock price today?
The current price of FRA:84C0 is €3.62. The 52 week high of FRA:84C0 is €9.72 and 52 week low is €3.56.
When is next earnings date of Clene Inc(FRA:84C0)?
The next earnings date of Clene Inc(FRA:84C0) is 2025-03-13 Est..
Does Clene Inc(FRA:84C0) pay dividends? If so, how much?
Clene Inc(FRA:84C0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers